Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis

被引：8
|
作者：
Christopeit, M. [1 ]
Badbaran, A. [1 ]
Zabelina, T. [1 ]
Zeck, G. [1 ]
Fehse, B. [1 ]
Ayuk, F. [1 ]
Wolschke, C. [1 ]
Kroeger, N. [1 ]
机构：
[1] Univ Med Ctr Hamburg, Dept Stem Cell Transplantat, Hamburg, Germany
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷 / 10期
关键词：
MYELOPROLIFERATIVE NEOPLASMS; COMPETING RISK; PROGNOSTIC IMPACT; CALR MUTATIONS; JAK2; CLINICIAN; 1-LIKE; GUIDE; MPL;
D O I：
10.1038/bmt.2016.128
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1391 / 1393
页数：3
相关论文
共 19 条
  • [1] Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation
    Panagiota, V.
    Thol, F.
    Markus, B.
    Fehse, B.
    Alchalby, H.
    Badbaran, A.
    Lehmannt, U.
    Koenecke, C.
    Shahswar, R.
    Chaturvedi, A.
    Stadler, M.
    Eder, M.
    Goehring, G.
    Koenigsmann, M.
    Kloos, A.
    Trummer, A.
    Schroeder, T.
    Kobbe, G.
    Thiede, C.
    Platzbecker, U.
    Schlegelbergers, B.
    Kreipe, H-H
    Ganser, A.
    Kroeger, N.
    Heuser, M.
    LEUKEMIA, 2014, 28 (07) : 1552 - 1555
  • [2] Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation
    Badbaran, A.
    Fehse, B.
    Christopeit, M.
    Aranyossy, T.
    Ayuk, F. A.
    Wolschke, C.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2016, 51 (06) : 872 - 873
  • [3] Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution
    Cabagnols, X.
    Defour, J. P.
    Ugo, V.
    Ianotto, J. C.
    Mossuz, P.
    Mondet, J.
    Girodon, F.
    Alexandre, J. H.
    Mansier, O.
    Viallard, J. F.
    Lippert, E.
    Murati, A.
    Mozziconacci, M. J.
    Saussoy, P.
    Vekemans, M. C.
    Knoops, L.
    Pasquier, F.
    Ribrag, V.
    Solary, E.
    Plo, I.
    Constantinescu, S. N.
    Casadevall, N.
    Vainchenker, W.
    Marzac, C.
    Bluteau, O.
    LEUKEMIA, 2015, 29 (01) : 249 - 252
  • [4] Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact
    Tefferi, A.
    Lasho, T. L.
    Finke, C.
    Belachew, A. A.
    Wassie, E. A.
    Ketterling, R. P.
    Hanson, C. A.
    Pardanani, A.
    LEUKEMIA, 2014, 28 (07) : 1568 - 1570
  • [5] Determinants of long-term outcome in type 1 calreticulin-mutated myelofibrosis
    Szuber, Natasha
    Lasho, Terra L.
    Finke, Christy
    Hanson, Curtis A.
    Ketterling, Rhett P.
    Pardanani, Animesh
    Gangat, Naseema
    Tefferi, Ayalew
    LEUKEMIA, 2019, 33 (03) : 780 - 785
  • [6] The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants
    Tefferi, Ayalew
    Lasho, Terra L.
    Tischer, Alexander
    Wassie, Emnet A.
    Finke, Christy M.
    Belachew, Alem A.
    Ketterling, Rhett P.
    Hanson, Curtis A.
    Pardanani, Animesh D.
    BLOOD, 2014, 124 (15) : 2465 - 2466
  • [7] Assessment of CALR mutations in myelofibrosis patients, post-allogeneic stem cell transplantation
    Haslam, Karl
    Langabeer, Stephen E.
    Molloy, Karen
    McMullin, Mary F.
    Conneally, Eibhlin
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (05) : 800 - 802
  • [8] Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation
    Kroeger, Nicolaus
    Panagiota, Victoria
    Badbaran, Anita
    Zabelina, Tatjana
    Triviai, Ioanna
    Cruz, Michelle Maria Araujo
    Shahswar, Rabia
    Ayuk, Francis
    Gehlhaar, Marten
    Wolschke, Christine
    Bollin, Robin
    Walter, Carolin
    Dugas, Martin
    Wiehlmann, Lutz
    Lehmann, Ulrich
    Koenecke, Christian
    Chaturvedi, Anuhar
    Alchalby, Haefaa
    Stadler, Michael
    Eder, Matthias
    Christopeit, Max
    Goehring, Gudrun
    Koenigsmann, Michael
    Schiegelberger, Brigitte
    Kreipe, Hans -Heinrich
    Ganser, Arnold
    Stocking, Carol
    Fehse, Boris
    Thol, Felicitas
    Heuser, Michael
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (07) : 1095 - 1101
  • [9] A triplex probe-based TaqMan qPCR assay for Calreticulin type I and II mutation detection
    Tang, Yigui
    Shi, Changgen
    Wu, Zhiyuan
    Fan, Ni
    Xu, Xiao
    Kang, Zhihua
    Zhang, Xinju
    Ma, Weizhe
    Guan, Ming
    HEMATOLOGY, 2019, 24 (01) : 26 - 31
  • [10] Laboratory methods of monitoring disease response after allogeneic haematopoietic stem cell transplantation for myelofibrosis
    Smallbone, Portia
    Louw, Alison
    Purtill, Duncan
    PATHOLOGY, 2024, 56 (01) : 24 - 32
12